TECFIDERA caps 120 mg 14 pce

7680628310014 CH-62831 L04AX07 01.99.0.

Reimbursement limitations:

TECFIDERA

Tecfidera est remboursé pour le traitement des patients âgés de 18 ans et plus atteints …

TECFIDERA caps 120 mg 14 pce
TECFIDERA caps 120 mg 14 pce
TECFIDERA caps 120 mg 14 pce
1 / 3
google

Details

Product number
6283101
CPT
-
Packaging group
14
Unit
Kapsel(n)
Composition
dimethylis fumaras 120 mg, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, talcum, silica colloidalis anhydrica, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, polysorbatum 80, natrii laurilsulfas, triethylis citras, talcum, simeticonum, Kapselhülle: gelatina, E 171, E 172 (flavum), E 133, Drucktinte: lacca, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 1.37 mg.

Articles (1)

Tecfidera 120 mg, magensaftresistente Hartkapseln
Magensaftresistente Hartkapseln
14
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/08/2024
Professional SmPC
Français
02/08/2024
Professional SmPC
Italien
02/08/2024
Patient information leaflet
Allemand
25/07/2024
Patient information leaflet
Français
25/07/2024
Patient information leaflet
Italien
25/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
1.37 MG Substance HBESI

Reimbursement information

Public price
CHF 287.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2014

Authorization holder

Biogen Switzerland AG

6340 Baar

Authorization information

Swissmedic authorization number
62831
Drug name
Tecfidera, magensaftresistente Hartkapseln
Galenic form
KAHAM
ATC Code
L04AX07
Authorization status
Z
Dispensation category
B
First authorization
07/08/2014
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Packaging details

Description (FR)
TECFIDERA caps 120 mg 14 pce
Description (DE)
TECFIDERA Kaps 120 mg 14 Stk
Market launch
07/08/2014
Narcotic (BTM)
No

Available generics

Dimethylfumarat Accord, magensaftresistente Hartkapseln
CHF 101.60
View
Dimethylfumarat Accord, magensaftresistente Hartkapseln
CHF 357.05
View
Dimethylfumarat Accord, magensaftresistente Hartkapseln
CHF 1038.40
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
CHF 113.05
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
CHF 403.05
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
CHF 1176.35
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
CHF 113.05
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
CHF 403.05
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
CHF 1176.35
View
Dimethylfumarat Spirig HC, magensaftresistente Hartkapseln
CHF 101.60
View

Other packaging sizes

TECFIDERA caps 240 mg 56 pce
56 KAP
View
TECFIDERA caps 240 mg 168 pce
168 KAP
View